NCT07833020 Gyrotonic Exercise in Lupus Adolescents Who Survived From Intensive Care
| NCT ID | NCT07833020 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Systemic Lupus Erthematosus |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-08-11 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-08-11 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
lupus adoelscented who recently survive from intenive care unit usually complain postintenive care unit syndrome in addition to stress, fatigue, low life quality, depression, low physical performance, low grip strenght, insomnia, weak cariorepsiratory fitness, and low physical capcity. gryotonic exercise may improve these problems
Eligibility Criteria
Inclusion Criteria: * childhood-onset lupus * adolescents who survived from intensive care unit * adlescents who are in risk of developing pos-tintenive care-unit syndrome (i.e patients who admitted to an intenive care unit for at least four days in last year) Exclusion Criteria: * mental diseases * upper or lower limb fractures
Contact & Investigator
Ali MA Ismail, lecturer
PRINCIPAL INVESTIGATOR
Department of Physical Therapy for Cardiovascular/Respiratory Disorder and Geriatrics
Frequently Asked Questions
Who can join the NCT07833020 clinical trial?
This trial is open to female participants only, aged 13 Years or older, up to 17 Years, studying Systemic Lupus Erthematosus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07833020 currently recruiting?
Yes, NCT07833020 is actively recruiting participants. Contact the research team at ali.mohamed@pt.cu.edu.eg for enrollment information.
Where is the NCT07833020 trial being conducted?
This trial is being conducted at Dokki, Egypt.
Who is sponsoring the NCT07833020 clinical trial?
NCT07833020 is sponsored by Cairo University. The principal investigator is Ali MA Ismail, lecturer at Department of Physical Therapy for Cardiovascular/Respiratory Disorder and Geriatrics. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.